Eden Research Share Discussion Threads

[neutralpov] 05/12/2022 15:46

Totally irrelevant to the (non-existent) prospects of this pariah of A.I.M.

An enrichment scheme and pension fund for the BoDs... scr#w the rest of the shareholders.

Re-emphasised target SP
EDEN.L 0.000p ZERO PENCE after a prepackaged admin

[supersonico] 05/12/2022 09:47

Botrytis of the vine: How to maintain quality in the harvest.

[supersonico] 04/12/2022 09:33

As we move further north of 0p the reiterations f.

[supersonico] 04/12/2022 09:33

Amati have gone but vast majority of investor base is rock solid and waits patiently for the Whales.

[neutralpov] 03/12/2022 15:26

Added 194,953.

Just when you think he couldn't possibly get stupider.... ;D

[supersonico] 03/12/2022 07:03

Atul keeps buying.

As of 30 September 2022, the number of shares in issue was 380,858,607.
As of 30 September 2022, significant shareholdings in the share capital of Eden Research plc were:

Number of shares % of the issued ordinary share capital

BGF Investment Management Limited
53,733,000
14.11%

Sipcam Oxon S.p.A.
37,614,830
9.88%

Hargreaves Lansdown
29,839,285
7.83%

Gresham House Asset Management Limited
27,845,445
7.31%


Canaccord Genuity Group Inc
22,584,000
5.93%

Interactive Investor
20,027,730
5.26%

JM Finn Nominees Limited
19,277,362
5.06%

Atul Unadkat
17,545,098
4.61%

Rathbone Nominees Limited
15,708,999
4.12%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.48%


......................................................................................................................

NUMBER OF AIM SECURITIES IN ISSUE
As of 09 March 2022, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 09 March 2022, significant shareholdings in the share capital of Eden Research plc were:

Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
54,933,000
14.44%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,331,396
6.66%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,386,275
5.36%

Interactive Investor
19,790,573
5.20%

Atul Unadkat
17,350,145
4.38%

Rathbone Nominees Limited
16,095,276
4.24%

Amati AIM VCT plc
14,282,652
3.76%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.49%



.....................................
NUMBER OF AIM SECURITIES IN ISSUE
As of 18 August 2021, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 18 August 2021, significant shareholdings in the share capital of Eden Research plc were:


Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
54,933,000
14.44%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,331,396
6.66%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,386,275
5.36%

Interactive Investor
19,790,573
5.20%

Rathbone Nominees Limited
16,122,338
4.24%

Amati AIM VCT plc
14,282,652
3.76%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.49%

...................


Home
SECURITIES INFORMATION


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 February 2021, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 21 February 2021, significant shareholdings in the share capital of Eden Research plc were:


Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
58,333,000
15.34%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,452,709
6.69%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,421,575
5.37%

Amati AIM VCT plc
16,937,750
4.45%

Rathbone Nominees Limited
16,156,166
4.25%

Interactive Investor
15,405,978
4.05%

HSBC Global Custody Nominee (UK) Limited
14,015,588
3.69%


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 August 2020, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 21 August 2020, significant shareholdings in the share capital of Eden Research plc were:


BGF Investment Management Limited
58,333,000
15.34%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Hargreaves Lansdown
30,276,493
7.96%

Gresham House Asset Management Limited
27,845,445
7.32%

Canaccord Genuity Group Inc
22,684,000
5.94%

JM Finn Nominees Limited
21,774,435
5.72%

Amati AIM VCT plc
16,937,750
4.45%

Rathbone Nominees Limited
16,246,373
4.27%

HSBC Global Custody Nominee (UK) Limited
14,007,734
3.68%

Interactive Investor
12,992,073
3.42%

[quazie12] 02/12/2022 23:37

£2 £4 FFs

[investingisatrickygame] 02/12/2022 13:21

Weyweyumfuzo & Super

As with attyG, I couldn't agree more.

Super said "That's really hard to say not just because we don't know the details around the pace and size of the roll out once approval is granted"

We do know a little bit about the pace and size of the rollout.

Slide 20 1/7/2021 AGM presentation

"This project represents Eden’s first foray into the use of its active ingredients and Sustaine® technology in seed treatments and the first use of its products and technology on broad acre crops, with promising future revenue potential in excess of €40 million in product sales per year."

2nd March Trading Update

"The seed treatment market is globally worth approximately US$6.5 billion annually with an estimated annual growth rate of between 10 and 12 percent. Eden estimates product sales arising from the successful development and registration of this seed treatment product may reach €20m per year in the short-term following launch with significant opportunities for growth in excess of this figure."

[neutralpov] 01/12/2022 21:41

Shut up, you disgusting ramper.

[attyg] 01/12/2022 18:49

Spot on Super.

[neutralpov] 01/12/2022 16:58

ravenna23, the funniest part of these delusional people's ravings is that you can compare what they're saying now to the forum chatter and RNSs from two, four, six+ years ago, and its the same recycled TRIPE!

;D

[weyweyumfozo] 01/12/2022 15:04

If Eden announced that field trials had been successfully completed on their seed treatment product, developed for commercialisation by Corteva, and applications for regulatory approval by the relevant authorities across the targeted geographies were being submitted, what would that do for the sp? Wasn't the run up to 20p two years ago based largely on the expectation of positive Corteva news?

[supersonico] 01/12/2022 12:52

As we move further north of 0p the reiterations fa .

[neutralpov] 01/12/2022 12:08

Change your meds, jismface... ;D


----


Reiterated target price:

EDEN.L

0.00 pence (ZERO PENCE)

[supersonico] 01/12/2022 11:43

As we move further north of 0p the reiterations fad .

[neutralpov] 01/12/2022 10:56

Restated target price:

EDEN.L

0.00 pence

[supersonico] 01/12/2022 06:37

Another field in China is "stuck neck", more serious than chips? Highly dependent on foreign seeds.

[supersonico] 01/12/2022 05:50

Corteva Agriscience Signs Agreement to Acquire Stoller Group, One of the Largest Independent Biologicals Companies in the Industry

[neutralpov] 30/11/2022 13:20

ravenna23 30 Nov '22 - 08:57 - 13483
> More jam tomorrow. Yet another approval, yet still no sales. Share price steadily increases on minimal volume. Hmm.

I disagree.

The company's core business is thriving - and making sales.

Sales of shares to duffers like the three mentally-challenged aggressive baboons above.

[weyweyumfozo] 30/11/2022 09:51

650,000 @ 6.25p - looks like a delayed trade buy.

[supersonico] 30/11/2022 09:20

As we move further north of 0p the reiterations fade a.

[ravenna23] 30/11/2022 08:57

More jam tomorrow. Yet another approval, yet still no sales. Share price steadily increases on minimal volume. Hmm.

[supersonico] 30/11/2022 07:21

Organic Certification in Greece

Greece is an important market for the commercialisation of both Mevalone and Cedroz with fruit and vegetable crops accounting for 18.8% of total agriculture production. Tomatoes are Greece's main vegetable export, shipping to 40 countries around the world, primarily in Europe, Middle East and USA. Between 2018 and 2021, the UK spent approximately EUR 22.5 million on average for supplies of Greek tomato products accounting for more than 36% of the total Greek turnover from agriculture exports of tomatoes.

Furthermore, in 2021, organic crops made up 10% of the country's agriculture and this figure is increasing year on year reflecting a rapidly growing market. This trend aligns with a broader transition to organic farming across Europe